Waters' Q3 Revenues Climb 13 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Waters today reported a 13 percent spike in third-quarter revenues, but reduced its earnings guidance for full-year 2011.

For the three months ended Oct. 1, the company saw revenues climb to $454.5 million, up from $401 million a year ago, driven by new instrument systems, including the Acquity H-Class UPLC, UPLC-mass spectrometer solutions, as well as strong TA Instruments product shipments, Douglas Berthiaume, president and CEO of Waters, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.